LeonaBio, Inc. Common Stock
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
LeonaBio, Inc. Common Stock represents the equity of LeonaBio, Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for high unmet medical needs. The company’s current pipeline centers on small-molecule treatments designed to restore neuronal health and address neurodegenerative conditions, including amyotrophic lateral sclerosis, Alzheimer’s disease, and Parkinson’s disease, as well as programs in oncology such as treatment-resistant metastatic breast cancer. LeonaBio also works on therapies for related neurological and neuropathic disorders, with several candidates in clinical development and early-stage research. Headquartered in Bothell, Washington, LeonaBio serves the biotechnology market through a portfolio aimed at advancing drug candidates from preclinical studies into human trials, making its common stock a way to track a company positioned at the intersection of neuroscience and precision therapeutics.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Mark J. Litton M.B.A., Ph.D.
- Employees
- 19
- Headquarters
- Bothell, WA, United States
- Website
- www.leonabio.com